Atlas Trials

Metastatic Castrate Resistant Prostate Cancer (mCRPC)

12 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Metastatic Castrate Resistant Prostate Cancer (mCRPC)

RecordFirmDate
RADIANT: A Study of Radium-223 Dichloride (Xofigo) vs Enzalutamide or Abiraterone (ARPIs, Androgen Receptor Pathway Inhibitors) in Patients With Prostate Cancer That Has Spread to the Bones (mCRPC, Metastatic Castration-Resistant Prostate Cancer) (NCT04597125)Bayer2020-11-09
The Safety and Tolerability of GT0918 in Subjects With mHSPC and mCRPC (NCT03899467)Suzhou Kintor Pharmaceutical Inc,2019-05-30
Investigating Safety, Tolerability and Efficacy of AZD5363 in Prostate Cancer. (NCT01692262)AstraZeneca2012-11-01

Track Metastatic Castrate Resistant Prostate Cancer (mCRPC) automatically

Every clearance here is in the API, with alerts when new ones post.